BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6216232)

  • 21. Binding of the nonprotein chromophore of neocarzinostatin to deoxyribonucleic acid.
    Povirk LF; Goldberg IH
    Biochemistry; 1980 Oct; 19(21):4773-80. PubMed ID: 6448634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neocarzinostatin biosynthetic gene cluster from Streptomyces carzinostaticus ATCC 15944 involving two iterative type I polyketide synthases.
    Liu W; Nonaka K; Nie L; Zhang J; Christenson SD; Bae J; Van Lanen SG; Zazopoulos E; Farnet CM; Yang CF; Shen B
    Chem Biol; 2005 Mar; 12(3):293-302. PubMed ID: 15797213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urea treatment and pronase digestion of antitumor protein antibiotics, auromomycin and neocarzinostatin.
    Suzuki H; Ozawa S; Tanaka N
    J Antibiot (Tokyo); 1980 Dec; 33(12):1545-50. PubMed ID: 6454671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiols screened by the neocarzinostatin protein for preserving or detoxifying its bound enediyne antibiotic.
    Chi HW; Huang CC; Chin DH
    Chemistry; 2012 May; 18(20):6238-49. PubMed ID: 22473745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton NMR studies of apo-neocarzinostatin from Streptomyces carzinostaticus. Sequence-specific assignment and secondary structure.
    Adjadj E; Mispelter J; Quiniou E; Dimicoli JL; Favaudon V; Lhoste JM
    Eur J Biochem; 1990 Jun; 190(2):263-71. PubMed ID: 2142075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-dimensional solution structure of apo-neocarzinostatin from Streptomyces carzinostaticus determined by NMR spectroscopy.
    Adjadj E; Quiniou E; Mispelter J; Favaudon V; Lhoste JM
    Eur J Biochem; 1992 Feb; 203(3):505-11. PubMed ID: 1531194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical investigations of neocarzinostatin in Japan.
    Kimura I
    Recent Results Cancer Res; 1978; 63():252-60. PubMed ID: 151899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological activities and physicochemical properties of pre-neocarzinostatin and UV-irradiated neocarzinostatin.
    Iseki S; Koide Y; Ebina T; Ishida N
    J Antibiot (Tokyo); 1980 Jan; 33(1):110-3. PubMed ID: 6445350
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro inhibition of human leukemic cells (CCRF-CEM) by agarose-immobilized neocarzinostatin.
    Lazarus H; Raso V; Samy TS
    Cancer Res; 1977 Oct; 37(10):3731-6. PubMed ID: 143343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-1027 enediyne chromophore: presence of another active form and its chemical structure.
    Otani T; Yoshida K; Sasaki T; Minami Y
    J Antibiot (Tokyo); 1999 Apr; 52(4):415-21. PubMed ID: 10395278
    [No Abstract]   [Full Text] [Related]  

  • 31. On the conformation of Phe78 of a chromoprotein antibiotic, neocarzinostatin.
    Imajo S; Ishiguro M; Tanaka T; Hirama M; Teplyakov A
    Bioorg Med Chem; 1995 Apr; 3(4):429-36. PubMed ID: 8581426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
    Napier MA; Goldberg IH
    Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-neocarzinostatin, a specific antagonist of neocarzinostatin.
    Kikuchi M; Shoji M; Ishida N
    J Antibiot (Tokyo); 1974 Oct; 27(10):766-74. PubMed ID: 4281770
    [No Abstract]   [Full Text] [Related]  

  • 34. Neocarzinostatin: effect of modification of side chain amino and carboxyl groups on chemical and biological properties.
    Samy TS
    Biochemistry; 1977 Dec; 16(25):5573-8. PubMed ID: 144523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary X-ray diffraction studies and biochemical characterization of the antitumor protein mitomalcin indicate close similarity to neocarzinostatin.
    Sieker LC; Gnanarajah GG
    Proteins; 1988; 3(4):252-5. PubMed ID: 2971216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of chromophore and apo-protein in neocarzinostatin action.
    Kappen LS; Napier MA; Goldberg IH
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):1970-4. PubMed ID: 6445563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NEOCARZINOSTATIN, AN ANTITUMOR ANTIBIOTIC OF HIGH MOLECULAR WEIGHT. ISOLATION, PHYSIOCHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES.
    ISHIDA N; MIYAZAKI K; KUMAGAI K; RIKIMARU M
    J Antibiot (Tokyo); 1965 Mar; 18():68-76. PubMed ID: 14326086
    [No Abstract]   [Full Text] [Related]  

  • 38. The promoting effect of amphotericin B on the incorporation of neocarzinostatin into human gastric cancer tissue.
    Nakazawa I; Ouchi E; Ishida N; Takano S; Ouchi K; Wagai K
    Tohoku J Exp Med; 1980 May; 131(1):101-2. PubMed ID: 6447386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Production of the antibiotic lienomycin in a culture of diastato chromogenes var. lienomycini].
    Gauze GF; Maksimova TS; Ol'khovatova OL; Kudrina ES; Il'chenko GB
    Antibiotiki; 1971 May; 16(5):387-90. PubMed ID: 5002219
    [No Abstract]   [Full Text] [Related]  

  • 40. Unstability of neocarzinostatin-chromophore.
    Edo K; Sato H; Saito K; Akiyama Y; Kato M; Mizugaki M; Koide Y; Ishida N
    J Antibiot (Tokyo); 1986 Apr; 39(4):535-40. PubMed ID: 2423490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.